Jul 27, 2026 06:09AM
May 18, 2026 06:08AM
May 23, 2025 06:39AM
May 23, 2025 06:30AM
May 22, 2025 04:05PM
May 22, 2025 04:01PM
Jan 16, 2025 06:01AM Outlook Therapeutics (OTLK) Reports Complete Twelve Week Efficacy and Safety Results of NORSE EIGHT Clinical Trial
Jan 16, 2025 06:00AM
Nov 29, 2024 06:02AM
Jul 30, 2024 09:10AM
Mar 27, 2024 08:15AM
Mar 18, 2024 05:10PM
Jan 23, 2024 08:47AM
Jan 23, 2024 08:00AM Outlook Therapeutics® Receives FDA Agreement Under Special Protocol Assessment (SPA) for 90 Day Non-Inferiority Study, NORSE EIGHT, and Announces Private Placement of Up to $172 Million to Advance ON
Aug 30, 2023 09:22AM
Aug 1, 2023 08:45AM
Dec 23, 2022 06:01AM
Dec 23, 2022 06:00AM
Nov 22, 2022 08:05AM
Oct 31, 2022 06:54AM

10,345 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All